Canandaigua National Bank & Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$506K Buy
+11,588
New +$537K 0.04% 237
2025
Q4
$463K Sell
4,861
-67
-1% -$6.57K 0.04% 240
2025
Q3
$481K Buy
+4,928
New +$510K 0.04% 244
2023
Q4
– Sell
-5,026
Closed -$265K – 269
2023
Q3
$265K Sell
5,026
-4,354
-46% -$228K 0.04% 214
2023
Q2
$507K Sell
9,380
-6,247
-40% -$326K 0.08% 171
2023
Q1
$782K Buy
+15,627
New +$736K 0.13% 150
2020
Q1
$401K Buy
+12,275
New +$480K 0.08% 168

Other funds holding BSX

Canandaigua National Bank & Trust's BSX Position: Q3 2026 in Review

Canandaigua National Bank & Trust opened a new position in Boston Scientific (BSX) in Q3 2026: 11,588 shares worth $506K. The stake represents 0.04% of the portfolio and ranks #237 among its holdings. This is a return to the name: Canandaigua National Bank & Trust previously reported a position in BSX as recently as Q4 2025.

Canandaigua National Bank & Trust first reported a position in BSX in Q1 2020 and has held it in 7 quarters since. The position peaked at $782K in Q1 2023. 49 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Canandaigua National Bank & Trust held 11,588 shares of Boston Scientific worth $506K as of Q3 2026.
  • Boston Scientific was a new Canandaigua National Bank & Trust position in Q3 2026.
  • Boston Scientific made up 0.04% of Canandaigua National Bank & Trust's portfolio in Q3 2026, its #237 holding.
  • Canandaigua National Bank & Trust first reported a position in Boston Scientific in Q1 2020 and has held it in 7 quarters since.
  • Canandaigua National Bank & Trust's Boston Scientific position peaked at $782K in Q1 2023.
  • 49 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Canandaigua National Bank & Trust's 13F filing for Q3 2026, filed 7 Oct 2026.